IN THE NEWS
Pierce Bainbridge Beats DQ Bid In $15M Malpractice Row
Law360 | August 2, 2019 — BakerHostetler on Thursday lost a bid to disqualify Pierce Bainbridge Beck Price & Hecht LLP from a $15 million malpractice case in California state…
Pierce Bainbridge Is Investigating Capital One’s Exposure of Over 100 Million Americans’ Sensitive Personal and Financial Information
Pierce Bainbridge Beck Price & Hecht LLP for PRNewswire | July 30, 2019 — Do you have a credit card with Capital One or have you applied for one at…
Pierce Bainbridge Sues the Kabbalah Centre on Behalf of Former Workers for Backpay and Other Damages
PRNewswire for Finance Yahoo | July 26, 2019 — Pierce Bainbridge Beck Price & Hecht LLP filed a lawsuit today against the Kabbalah Centre, related corporate entities, and Kabbalah Centre…
PRACTICE AREAS
Intellectual Property Litigation
Health Care Law
Internal Investigations
Commercial Litigation
NOTABLE REPRESENTATIONS
Represented Amgen in biosimilar litigation pursuant to the Biologics Price Competition and Innovation Act (“BPCIA”) regarding competitors’ proposed filgrastim and proposed pegfilgrastim products.
Represented Spansion in International Trade Commission investigation regarding read/write operations in flash memory devices.
Member of trial team representing Samsung in International Trade Commission investigation regarding LTE/4G wireless communications standards.
Member of trial team representing Motorola in litigation regarding F/RAND royalty rates for patents related to 802.11 (Wi-Fi) and H.264 video compression standards.
Represented Motorola in patent litigation regarding features of graphical user interfaces.
Represented Motorola in patent litigation regarding communications session technology relating to persistent communication sessions across multiple user devices.
Represented GN ReSound regarding wireless communication techniques used in hearing aids.
Represented Wyeth/Pfizer in ANDA litigation regarding broad-spectrum antibiotic.
Represented university client in dispute over joint inventorship of patent related to synthetic peptides.
Represented Goldman Sachs in litigation regarding contract dispute resulting from sale of voice recognition software company.
Represented client in connection with FCPA investigation.
Represented pharmaceutical client in connection with government investigation on drug pricing.
NOTABLE CLIENTS
Amgen
Genetech
Pfizer
Samsung
Motorola Mobility
EDUCATION
J.D., Fordham University School of Law
Ph.D., University of Pennsylvania
A.B., Bowdoin College
PREVIOUS ASSOCIATIONS
Associate
Ropes & Gray LLP
Associate
Paul, Weiss, Rifkind, Wharton & Garrison LLP
ADMISSIONS
State Bar of New York
State Bar of Massachusetts
THOUGHT LEADERSHIP
Panelist, “Best Practices In Patenting Precision Medicine,” at the Life Sciences Patent Network North America’s Spring Conference, April 25, 2019, Boston.
Hiro Hagiwara, Steve Baughman, Gene Lee, Conor McDonough, Joint and Divided Infringement: Navigating the Changing Landscape for Multiple Actors and Distributed Systems under U.S. Patent Law, 62 Japan Int. Prop. Assoc. 265 (2015)
Herman, Kenneth B., Scarpati, Jennifer, McDonough, Conor Brew, Faster Regulatory Path for Follow-On Biologics is a Win for Pharma, 6 Pharma Mag. 46 (2010)
